Description
Description tell about chairman emeritus retired chairman and chief executive officer rockwell partner.
UC Innovation Council
DONALD R. BEALL
Chairman Emeritus/Retired Chairman & CEO
Rockwell
Partner, Dartbrook Partners, LLC
JAMES BRAILEAN
co-Founder & Managing Partner of
BFT Equity Partners and KARMEL Capital
BROOK BYERS
Senior Partner
Kleiner, Perkins, Caufield & Byers
FRED COHEN
Partner,TPG
co-Founder,TPG Biotechnology
MARK CROWELL
Innovation and Business Development
Consultant
(former) Executive Director, University of
Virginia
JERRY FIDDLER
Founder
Wind River Systems
RODNEY GLOVER
Partner (retired)
Wiley Rein, LLP
JOSH GREEN
General Partner
Mohr Davidow
Chairman
BRUCE HALLETT
Managing Director
Miramar Venture Partners
LESLIE HICKLE
VP Business Development
BioAtla
HADI MAKARCHIAN
Regent of the University of California
Chairman, Makar Properties
Board of Directors and Banning Lewis Ranch
Management Company
ALAN MENDELSON
Partner
Latham & Watkins LLP
TONY OLIVEIRA
Senior Advisor
AGR Partners
Managing Partner, Oliveira Farming
NANCY OLSON
Managing Partner (retried)
Fog City Fund
KISH RAJAN
Director
Governor’s Office of Business and Economic
Development
EDUARDO RALLO
Managing Partner
Pacific Community Management
ANN MARIE SASTRY
co-Founder and CEO
Sakti3
SUE SIEGEL
CEO, GE Ventures &
healthymagination
07.29.2014 Innovation Al liances &
Services
UNIVERSITYOFCALIFORNIA.EDU 01
DONALD R. BEALL
CHAIRMAN EMERITUS
RETIRED CHAIRMAN & CHIEF EXECUTIVE OFFICER
ROCKWELL
PARTNER, DARTBROOK PARTNERS, LLC
Beall retired from Rockwell in 1998 after a 30-year career. He served as Chairman/CEO or
President/COO for 20 years. Rockwell was a global leader in aerospace, electronics and automotive
markets. Through a series of strategic actions, the company became focused on a diversified group of
leadership electronics businesses serving factory automation, communications, avionics and various
communications-semiconductor world markets. Those electronics businesses today are represented by
three public companies through which significant shareowner value has been created.
He is a former director of Amoco, ArvinMeritor, Baker Hughes Corporation, Conexant Systems, CT
Realty, Interfirst Corporation, Mindspeed Technologies, Proctor & Gamble, Rockwell, Rockwell Collins,
Skyworks Solutions and Times Mirror. Currently, he is a partner in Dartbrook Partners, LLC (a family
partnership) and the chairman of the Beall Family Foundation. His wife, J oan, and their two sons, J eff
and Ken, are active in the management of both Dartbrook Partners and the Beall Family Foundation. The
Beall Family Foundation has endowed the Don Beall Dean of Engineering at San J ose State University;
the Donald R. Beall Chair in Strategic Management at the University of Pittsburgh; and $5 million to fund
the Don Beall Center for Innovation and Entrepreneurship at the UCI Paul Merage School of Business,
which has since been transferred to establish the new UCI Institute of Innovation. The Foundation
continues to provide significant annual support to the Beall Center in the Merage School.
Beall is very involved with the University of California Irvine. He serves on several advisory boards and
executive committees in a number of disciplines including: the UCI Paul Merage School of Business
Dean’s Advisory Board, Executive Committee, and the Don Beall Center for Innovation and
Entrepreneurship Advisory Board; UCI Henry Samueli School of Engineering Advisory Board; UCI J oan
and Don Beall Center for Art +Technology Advisory Board; UCI Medical Center CEO Advisory Board;
Advisor to the newly-appointed Executive Director of the UCI Institute for Innovation and member of the
UCI Chief Executive Roundtable. He is an advisor to the San J ose State University School of
Engineering and member of the Engineering Leadership Council. He is a trustee and President’s Circle
member of the Naval Postgraduate School Foundation, and serves as an Overseer of the Hoover
Institution at Stanford. Beall’s membership involvements include: Business Executives for National
Security; The Presidents’ Circle of National Academies of Science, Engineering & Medicine; the Old
Capital Club of Monterey; the Bohemian Club of San Francisco; numerous Young Presidents
Organization alumni groups; and member and past chairman of the Conquistadores del Cielo. He is a
Fellow of the American Institute of Aeronautics and Astronautics. Beall was a member of the board of
governors and past chairman of the Aerospace Industries Association of America (AIA) and was a trustee
of the California Institute of Technology for many years.
Upon his retirement, Beall and his wife, J oan, were honored by Rockwell through the initial funding and
establishment of the J oan and Don Beall Center for Art +Technology, UCI. Continuing significant support
for the Center is provided by the Beall Family Foundation. Other past honors include: 2014 Claire Trevor
Commemorative Star, UCI Claire Trevor School of the Arts, shared with J oan; 2008 SJ SU Tower Award (San
J ose State University's highest honor); 2001 UCI Medal; 1998 Horatio Alger Award; 1996 Human Relations
Award from the Orange County Chapter of the American J ewish Committee, shared with J oan; and 1996
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 01
Front & Center Award as Orange County Person of the Year, presented by California State University
Fullerton.
Beall received an engineering degree from San J ose State University and an MBA from the University of
Pittsburgh. Both institutions have honored Beall with distinguished alumnus awards. Beall also received
the 1991 Exemplary Leadership in Management Award from the J ohn E. Anderson School of
Management, UCLA. He is involved in numerous professional, educational, public service and
philanthropic endeavors and is an investor, director, and/or advisor with several venture capital groups,
individual companies and investment partnerships.
Beall has been married for more than 50 years to J oan. They have two married sons, two
granddaughters, three grandsons and one great-grandson. They reside in Corona del Mar and Pebble
Beach, California.
JAMES C. BRAILEAN
CO-FOUNDER AND MANAGING PARTNER
BFT EQUITY PARTNERS AND KARMEL CAPITAL
J ames Brailean, PhD, is the co-founder and managing partner of BFT Equity Partners and KARMEL
Capital. Dr. Brailean started BFT Equity Partners in J anuary of 2013. The fund focuses on investments in
early stage companies with disruptive technology or manufacturing processes. The fund has made five
investments ranging from Intelligent Blends, manufacturer of single serve drinks, to BURL Concepts, a
company developing a portable medical device to enable the detection of stroke in pre-hospital settings.
KARMEL Capital was founded by Dr. Brailean and his partner Scott Neuberger. KARMEL Capital is a
Private Equity fund with a focus on unlocking value by bringing operational excellence and strategic
direction to technology companies. KARMEL’s principals partner with current investors/owners to create a
turnaround strategy and a win/win deal structure for all stakeholders. In J une of 2013, KARMEL Capital
acquired 85% of the Qualcomm subsidiary, Snaptracs. In March of 2014 Karmel Capital successfully
partnered with Parallax Partners and Stepstone Capital to acquire the DivX business unit from Rovi
Corporation (NASDAQ ROVI). Dr. Brailean is currently serving as a director on the board of directors of
both Snaptracs and DivX.
Prior to starting BFT Equity Partners and KARMEL Capital, Dr. Brailean founded PacketVideo in 1998
and became its CEO in 2000. Under Dr. Brailean's leadership, PacketVideo launched the world's first
commercial end-to-end wireless mobile media delivery platform in 2000, and helped create a new
industry for wireless multimedia communications. PacketVideo was acquired by NTT DOCOMO, a large
J apanese telecommunications company, in October 2010. In J anuary of 2013 after 14.5 years of leading
PacketVideo and shipping more than 700 million pieces of software worldwide, Dr. Brailean stepped
down as CEO.
Dr. Brailean has previously served on several public and private company boards including DivX
(NASDAQ DIVX), Sonic Solutions (SNIC), NextWave (NASDAQ WAVE), Wireless On-ramp, Perseus
Wireless, and Nik Software. Currently, Dr. Brailean serves on the boards of Micropower Technologies,
Inteligent Blends, Burl Concepts, Snaptracs and DivX. Dr. Brailean also served on both AT&T’s and
Verizon Wireless’ Application Developer Advisory Boards from 2007 to 2010. From 2000 to 2004, Dr.
Brailean served on the advisory board of DOCOMO Labs USA..
Dr. Brailean received his doctorate of philosophy in electrical engineering from Northwestern University.
He holds a MSEE from USC and a BSEE from the University of Michigan - Dearborn. Dr. Brailean has 17
patents in the area of video compression and transmission. He is a recipient of the Lifetime Achievement
Award from the Mobile Entertainment Forum for his contributions to the acceleration of the development
and adoption of mobile multimedia services worldwide.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 02
BROOK BYERS
SENIOR PARTNER
KLEINER, PERKINS, CAUFIELD & BYERS
A venture capital investor since 1972, Brook has been closely involved with more than 60 new
technology-based ventures, many of which have become public companies. He formed the first life
sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier
venture capital firm in the medical, healthcare and biotechnology sectors. KPCB has invested in and
helped build more than 110 life sciences companies that have developed hundreds of products to treat
underserved medical needs for many millions of patients. Brook was the founding president and then
chairman of four biotechnology companies that were incubated in KPCB's offices and went on to become
public companies with an aggregate market value of more than US$8 billion. He serves on the board of
directors of CardioDX, Crescendo, Elcelyx, Foundation Medicine, Oculeve, Pacific Biosciences, Inc.,
Veracyte, XDx, Inc. and Zephyr Health. Formerly, Brook served as a director of Idec Pharmaceuticals
(chairman), Athena Neurosciences (chairman), Signal Pharmaceuticals, Onyx Pharmaceuticals, Hybritech
(chairman), Genprobe and others. These companies pioneered the medical use of molecular biology,
monoclonal antibodies, personalized medicine, molecular diagnostics, genomics and sequencing. He also
previously served as the president and a director of the Western Association of Venture Capitalists. Brook
is on the Board of Trustees of Stanford University, a board member of the University of California, San
Francisco, Medical Foundation and the New Schools Foundation. In 2007, UCSF awarded Brook the
UCSF Medal, its honorary degree equivalent. In 2008, Brook was elected a fellow of the American
Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National
Venture Capital Association. In 2010, he received an honorary Ph.D. from Georgia Institute of
Technology. Brook is a former director of the Entrepreneurs Foundation, the Asian Art Museum in San
Francisco and the Georgia Tech Advisory Board. He was also a founder of TechNet. Raised in Atlanta,
Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and
received an M.B.A. from Stanford University.
FRED E. COHEN
PARTNER, TPG
CO-FOUNDER, TPG BIOTECHNOLOGY
Fred Cohen is a Partner at TPG and co-founder of TPG Biotechnology, a life science focused investment
effort. He is also an Adjunct Professor of Cellular and Molecular Pharmacology at the University of
California, San Francisco.
For the last 13 years, Dr. Cohen has been at TPG where he has been responsible for co-leading the
Biotechnology investment effort. The Biotechnology team has invested in over 50 companies covering
areas of Drug Discovery and Development, Personalized Medicine, Allied Pharmaceutical Services,
Industrial Biotechnology and Medical Technology. The group was formed in 2002 and has recently
initiated its fourth fund. Currently, TPG Biotechnology manages over $1 Billion in assets and is an
integral part of the firm’s larger healthcare efforts.
For the last 30 years, Dr. Cohen has been at UCSF where he has held various clinical responsibilities as
an Internist for hospitalized patients, a consulting Endocrinologist, and as the Chief of the Division of
Endocrinology and Metabolism. His research interests include structure based drug design, prion
diseases, computational biology and heteropolymer chemistry. Dr. Cohen has published over 200 peer
reviewed articles, participated as a co-inventor on over 10 patents and has served as an editor or editorial
board member of several international scientific journals.
Dr. Cohen received his BS degree in Molecular Biophysics and Biochemistry from Yale University, his
D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his MD from Stanford and his
postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 03
He is a Fellow of the American College of Physicians and the American College of Medical Informatics
and a member of the American Society for Clinical Investigation and Association of American Physicians.
Dr. Cohen has received several awards for his work including a Searle Scholarship, Young investigator
awards from the Endocrine Society and the Western Society for Clinical Investigation, and the LVMH
Science pour l’art prize (shared with Stanley Prusiner). Dr. Cohen was elected to the Institute of Medicine
of the National Academy of Sciences in 2004 and the American Academy of Arts and Sciences in 2008.
Dr. Cohen currently serves on the Board of Directors of several biotechnology and pharmaceutical
organizations including Biocryst(BCRX), CareDx(CDNA), Five Prime Therapeutics(FPRX), Genomic
Health(GHDX), Quintiles Transnational(Q), Rapid Micro Biosystems, Roka(ROKA), Tandem
Diabetes(TNDM), and Veracyte(VCYT). He also serves on the board of Autistica, a UK based autism
research charity.
Fred lives in San Francisco with his wife, Carolyn Klebanoff M.D., and his three children, Alison, Michael
and J ane. Drs. Klebanoff and Cohen were founders of Sweetwater Spectrum, a non-profit organization
that creates and runs planned communities for adults with autism. Dr. Klebanoff currently serves as the
Board Chair and Dr. Cohen is a member of the advisory board.
MARK CROWELL
INNOVATION AND BUSINESS DEVELOPMENT CONSULTANT
(FORMER) EXECUTIVE DIRECTOR, UNIVERSITY OF VIRGINIA
Mark Crowell is an internationally-known practitioner and consultant in areas related to university
innovation and business development, proof-of-concept and translational research initiatives, university-
industry (and foundation) research partnerships, and innovation and entrepreneurial ecosystem
development strategies. Mark currently consults for and advises such organizations as the World Bank,
BIO, PhRMA, the Arkansas Research Alliance, Eva Klein & Associates, Maximus, Research Triangle
Institute, and a number of university clients.
From 2010-2014, Mark was the founding Executive Director of UVa Innovation at the University of
Virginia (and Associate Vice President for Research). In one of the nation’s first pan-university “chief
innovation officer” roles, Mark led the re-engineering and integration of the university’s technology
transfer, business development, industry and foundation research, and innovation policy and advisory
services; in addition, he worked to establish collaborative mechanisms between UVa Innovation and
entrepreneurship education, innovation challenge, Darden iLab, Open Grounds, and related initiatives
across the university. Key accomplishments within UVa during Mark’s tenure included numerous new
company launches, accelerated time frames for “lab to market” for promising UVa discoveries, enhanced
numbers of licenses and partnerships with industry and foundations, and a national “best-in-class”
process for managing translational research and proof-of –commercial-readiness projects. In May 2014,
the US Chamber of Commerce recognized UVa Innovation with its “Champion of Intellectual Property”
Award for its work in advancing innovation and intellectual property.
Mark advises key leaders and policy development groups, including the NIH, US Congress, AAMC
Council of Deans, and many others. He testified twice in Congress about the critical need for more
resources to address the “translational gap” between basic discovery and market readiness, leading to
the introduction of a key piece of legislation, the “Transfer Act of 2013”, in which his testimony was cited
as a catalyst for newly proposed initiatives. As a result of his effectiveness in advocating for support for
best practices in university innovation management, Mark was invited by the White House to the
presidential signing ceremony for the America Invents Act.
While leading UVa Innovation, Mark was – and remains – extremely active and engaged in national and
international advisory and advocacy work related to university innovation and business development. He
chairs BIO’s Technology Transfer Committee and has chaired the Translational Research Forum at the
last four BIO International Conventions. His impact and visibility leads to frequent invitations to speak
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 04
and share best practices in settings around the US, including a fall 2013 invitation from the Office of US
Senator Max Baucus to speak at the Montana J obs Summit 2013 (featuring speakers like Elon Musk,
Sheryl Sandberg, and other prominent CEOs of Fortune 500 and high growth, high success startups).
Mark’s most recent international consulting work includes innovation capacity building initiatives in
Eastern Europe on behalf of the World Bank, innovation policy and best practices advisory projects in
South America on behalf of BIO, and keynote addresses at international conferences and symposia in
such places at Singapore, China, Thailand, J apan, and Brazil.
Before going to UVa in 2010, Mark served as Vice President for Business Development at the Scripps
Research Institute in La J olla, CA, and J upiter, FL, following a long career in Research Triangle Park,
North Carolina, where he led the innovation, technology transfer, and industry research enterprises for
Duke (1987-1992), North Carolina State University (1992-2000), and the University of North Carolina at
Chapel Hill (2000-2008). During the past 25 years, the technology transfer programs Mark has directed
have helped to launch more than 135 start-up companies, as well as numerous products and services.
He also played a major role in the development of research campuses in the Research Triangle region
and co-founded a university-related venture capital fund.
Crowell was the 2005 President of the Association of University Technology Managers (AUTM). In 2013,
he was awarded AUTM’s highest award, the “Bayh-Dole Award”, given “in recognition of the recipient’s
untiring efforts to foster and promote intellectual property activities on behalf of the university and
nonprofit community.”
JERRY FIDDLER
FOUNDER
WIND RIVER SYSTEMS
J erry Fiddler is the founder of Wind River Systems (NASDAQ:WIND), a company which he started in
1981 in his Berkeley garage. Since then, Wind River has grown to become the leading provider of device
software worldwide with over 1,100 employees in 16 countries. Through the company's dramatic growth,
Fiddler's role evolved from that of the sole programmer to CEO and Chairman of the Board until his
departure in 2004. While doing so, he gained a reputation as an expert in the design and implementation
of real-time systems." Since beginning his career at Lawrence Berkeley Lab, Fiddler has published and
presented many technical papers and articles and has been the keynote speaker for numerous
conferences worldwide. Mr. Fiddler sits on several corporate boards, including Wind River, Tensilica,
Crossbow and Nanochip, as well as a number of advisory boards.
RODNEY H. GLOVER
PARTNER (RETIRED)
WILEY REIN, LLP
After thirty years of the practice of law in Washington, DC, Mr. Glover retired in 2009. During his career,
his practice focused primarily on representing venture capital firms and technology-based companies
providing services including corporate litigation, analyzing and negotiating corporate acquisitions and
serving as outside general counsel to some of his long-standing clients. Mr. Glover also represented
several science-based not-for-profits on a variety of issues including corporate governance, compliance,
government contracts, employment matters and day-to-day legal operations.
Mr. Glover served as counsel for and later as a board member of the Bermuda Institute of Ocean
Sciences (“BIOS”) from 2006-10 where he provided advice on matters such as ship acquisitions, appeals
from NSF grant denials, and a wide variety of corporate matters. After moving to the San Diego area Mr.
Glover joined the Advisory Council of Scripps Institution of Oceanography in 2012. In 2013 he was
selected to join the UCSD Innovation Advisory Board where he has worked on a number of projects to
advance innovation there.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 05
Mr. Glover’s interest in ocean science is a continuation of his life-long passion for the oceans that began
as a child during family vacations on Cape Cod. This interest was further kindled during his sophomore
year at the University of Maryland when he was selected by the Department of Defense to be one of eight
undergraduates to spend 4 months on an oceanographic research vessel in the Pacific and Indian
Oceans conducting surveys and experiments relating to tectonic plate shifting and sea-floor “hot spots.”
JOSH GREEN
GENERAL PARTNER
MOHR DAVIDOW VENTURES
J osh Green has been a venture capitalist since 2006 and his investments include a wide range of
startups and today is focused on places where information technology meets the analog world.
In a 25-year career in law prior to venture capital, J osh built two law firms to 150 lawyers each and acted
as an advisor to some of Silicon Valley’s legendary startups in the computer, Internet,
telecommunications, biotech and medical device industries. J osh gained a breadth of knowledge that
makes him uniquely qualified for an investment area that spans multiple industries. He served as
Chairman of the National Venture Capital Association in a term ended May 2014.
Facts & Stats
Graduated magna cum laude from UCLA in 1977 and the UCLA School of Law in 1980 where he was on
the Law Review
Founder of the UCLA Venture Capital Fund,
Undergraduate commencement speaker at UCLA
High school basketball coach for eight years
Formerly included on Forbes Midas List of dealmakers
J osh helped more than 150 companies complete successful IPOs, over 100 companies complete M&A
transactions and 1000 venture capital financings
Favorite Quote: “Be more concerned with your character than your reputation, because your character is
what you really are, while your reputation is merely what others think you are” – Legendary UCLA Head
Basketball Coach J ohn Wooden.
BRUCE HALLETT
MANAGING DIRECTOR
MIRAMAR VENTURE PARTNERS
Bruce Hallett is a co-founder of Miramar Ventures and brings his enthusiasm for innovation, product
strategy and team building to Miramar’s portfolio of tech start-up companies. With over two decades of
collaborations with technology entrepreneurs, Bruce leads Miramar investments in mobile Internet
solutions and software. Currently, he serves on the board of directors of Brand Affinity Technologies and
WellTok. He also served on the boards of Aktino (acquired by Positron), Berkana Wireless (acquired by
Qualcomm), OptionEase (acquired by Solium) and RealPractice (acquired by ReachLocal).
Prior to founding Miramar, Bruce was Managing Partner of the Brobeck, Phleger & Harrison Orange
County office, where he orchestrated initial public offerings, venture financings and liquidity events for
many high profile technology companies in Southern California, including Broadcom, Buy.com, Exult and
Applied Semantics (acquired by Google in 2003). Bruce was one of seven partners on Brobeck’s firm-
wide executive committee until he started Miramar in 2001.
Bruce received his BA magna cum laude from UC Irvine and his J D from UCLA. He is currently President
of the UC Irvine Alumni Association. From 2007-2010, he was Chair of the Chief Executive Roundtable
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 06
at UC Irvine, a group of business leaders committed to building mutually beneficial, strategic partnerships
between the university and the community. Bruce also serves on the Board of Directors of OCTANe.
From 2010-2012, Bruce served as UC Alumni Regent on the Board of Regents of the University of
California.
LESLIE HICKLE
VICE PRESIDENT BUSINESS DEVELOPMENT
BIOATLA
Dr. Leslie Hickle is Vice President Business Development for BioAtla, a San Diego biopharmaceutical
company developing novel drugs and protein engineering platforms based on bioactive proteins such as
antibodies and enzymes. She has extensive research and management leadership experience in animal
health, agribusiness, and industrial biotechnology and transactional experience across multiple industries
leading to several legacy products with multi-million dollar sales. Prior to joining BioAtla, she managed the
San Diego headquarters and led corporate development for Synthetic Genomics, a company founded by
Dr. Craig Venter to progress the development of biobased fuels and synthetic biology. Previous to SGI,
while at Diversa, AgriLynx, Mycogen and Stauffer Chemical (now Syngenta) she played critical rolls in
identifying and fostering strategic alliances with key partners in animal health, plant agriculture and
industrial businesses. She has led and mentored teams that have developed novel chemical and
biopesticides, plant traits, vaccines, therapeutics, and technology platforms; she is co- inventor on issued
and pending patents, is editor of a book on analytical chemistry, and co-author of publications in animal
health and agriculture. She has founded successful biotech companies and served as a business and
technical consultant to Bayer, California EPA, Schering Plough, Pioneer Hi-Bred, DuPont, Dow Chemical,
Cal Poultry Federation and several biotech startups. Dr. Hickle received both her BS (1974,
Biology/Chemistry) and PhD (1981, Entomology/Toxicology) from the University of California Riverside.
Leslie is a Certified Board of Director (UCLA Anderson School of Business) and continues to advise and
work with new biotech startups; she also serves on UC Riverside Board of Advisors for the College of
Natural and Agricultural Sciences.
HADI MAKARECHIAN
REGENT OF THE UNIVERSITY OF CALIFORNIA
CHAIRMAN, MAKAR PROPERTIES
BOARD OF DIRECTORS AND BANNING LEWIS RANCH MANAGEMENT COMPANY
Hadi Makarechian serves as Chairman of Makar Properties Board of Directors and Banning Lewis Ranch
Management Company. He received his B.S. in Civil Engineering and his B.A. in Economics from the
State University of New York. Prior to his retirement in J une 2008, Mr. Makarechian served as chief
executive officer and chairman of the board of directors of Capital Holdings, Inc., a company he founded
in 1991. He also founded and served as president of Shamron Corporation from 1979 to 1991.
ALAN C. MENDELSON
PARTNER
LATHAM & WATKINS LLP
Mr. Mendelson is a corporate attorney, primarily representing biotechnology and medical device emerging
and growth companies and has been a partner at Latham & Watkins LLP since 2000. He currently
serves as co-chair of Latham’s Life Science Industry Group and served as co-chair of its Emerging
Companies Practice Group from 2001-13. Prior to joining Latham, he was with Cooley LLP from 1973-
2000.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 07
Mr. Mendelson served as president and a board member of the National Kidney Foundation of Northern
California, Inc. for fifteen years, as a member of the Board of Overseers Visiting Committee of Harvard
Law School for six years, as a member of the Board of Trustees of The Scripps Research Institute from
2012-14. Mr. Mendelson served as president of the Cal Alumni Association from 2009-11 and as an
alumni member of the UC Board of Regents from 2011-13. He currently serves as a member of the Major
Gifts Council for the Lucile Packard Foundation for Children's Health and as a member of the Board of the
American Friends of Rambam Medical Center, Haifa, Israel.
Mr. Mendelson has been recognized as one of America's 100 most influential lawyers by the National
Law J ournal in the 1994, 1997, 2000 and 2006 editions of the National Law J ournal. In March 2010, Mr.
Mendelson was honored at the annual Salute to Excellence dinner sponsored by the American Liver
Foundation for those who have made an outstanding contribution to biotechnology and medical
innovation. In 2012, the Cal Alumni Association recognized him for his “Excellence in Service” to UC
Berkeley. In 2013, he was named to Euromoney’s Life Sciences Hall of Fame, and in December 2014,
Mr. Mendelson will receive the Life Sciences Leadership Award from BayBio at its 11th annual Pantheon
Awards ceremony.
TONY OLIVEIRA
SENIOR ADVISOR
AGR PARTNERS; MANAGING PARTNER, OLIVEIRA FARMING
Currently serving as an advisor to AGR, Tony Oliveira brings more than 40 years of experience as a
multinational agribusiness executive, farmer, economics professor and public servant. He is the
managing partner of Oliveira Farming, a diversified farming operation in California's Central Valley.
Oliveira provides consulting services through Oliveira Advisory Services and Funston Advisory Work
Services, both of which focus on pension issues with an emphasis on asset liability and sustainability, and
risk management. He is a practicing economist, advising companies on economic trends with a focus on
agricultural investments and commodity trends. While working as CEO at Dalgety PLC in London for six
years, he was part of a small team that developed revolutionary patents for the fresh produce sector.
Oliveira has also been active in the public sector: he served on the California Public Employees
Retirement System (CalPERS) board, the Kings County Board of Supervisors, and the California State
Association of Counties (CSAC) board. He has also been teaching economics and business at West Hills
College in Lemoore since 2000. Tony received his M.B.A. from Pepperdine University and is a Ph.D
candidate in Public Policy at Walden University, currently completing his dissertation in the sustainability
of public and private pension funds through best practice benchmarking of the asset/liability study (ALS)
process. He has completed Fiduciary and Pension Management programs at Stanford Law School. He is
also a songwriter, composer and performer. He and his wife live in Lemoore.
NANCY OLSON
MANAGING PARTNER (RETIRED)
FOG CITY FUND
Ms. Olson was a venture capitalist for 25 years. She is the retired founder and managing partner of Fog
City Fund, a venture fund that invested in life science and medical companies. She was previously a
general partner at St. Paul Venture Capital and Sequoia Capital. She has served as a trustee of
Hampshire College, a director of the San Francisco Opera Association, and a board member of Girl
Scouts of San Francisco Bay Area. Her UCB campus affiliations include UC Berkeley Foundation trustee
(2001-2013), Graduate Fellowship Advisory Committee, College of Letters & Science Executive Board
(1999-2007) and board president (2004-2007), Health Science Initiative Volunteer Committee, supporter
of the Biology Fellows Program, On the Same Page, and founder/sponsor of IDEAL Scholarships and
SMART program. She is a Builder of Berkeley, a Berkeley Fellow, and recipient of the Trustees’ Citation.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 08
KISH RAJAN
DIRECTOR
GOVERNOR’ S OFFICE OF BUSINESS AND ECONOMIC DEVELOPMENT
Kish Rajan serves as Director of the Governor's Office of Business and Economic Development. He
brings to the job a 20-year track record of success in both government and the private sector. After
graduating from UC Berkeley, Kish Rajan began his public sector career on Capitol Hill as an aide first to
United States Senator Barbara Boxer and then later to Phil Angelides who went on to become California
State Treasurer.
Kish left to build a 14 year career in the private sector as a business development executive in the mobile
technology arena, managing vital business partnerships that created hundreds of jobs and millions of
dollars of shareholder value. While building this successful business career, Kish earned a J D, started a
family, and settled back in his hometown of Walnut Creek, CA. In 2008, Kish re-entered public service
when was elected to the Walnut Creek City Council. Drawing on his political and business experience
Kish became a regional leader who advocated for transportation improvement, education and economic
development. In 2012, Governor Brown appointed Kish Rajan as the GO-Biz director to lead the
executive team. His directive from Governor Brown is to enhance California’s job creation effort by
streamlining business regulations, promoting statewide economic development and fostering greater
international trade opportunities.
EDUARDO RALLO
MANAGING PARTNER
PACIFIC COMMUNITY MANAGEMENT
Eduardo Rallo is Managing Partner of Pacific Community Management, a leading impact investing firm,
and sits on the boards of ICU Eyewear, Freshology, and Pacific Pharmacy Group.
Additionally, Eduardo is Chairman and Co-Founder of Resmex Group, Inc., which manages six restaurant
concepts in the Bay Area and has over 400 employees. He is also Co-Founder of Milagros de Mexico a
pharmacy chain focused on the Hispanic market. Prior to joining PCV, Mr. Rallo co-founded World
Wrapps Restaurants and oversaw its growth to a 26-store chain. Mr. Rallo also co-founded and served
as Managing Director of BrainStorm Ventures, an early stage investment fund, which has invested in 24
companies, including Opentable.com, Zappos.com and Me.com.
Eduardo sits on the non-profit boards of Universal Giving and Silicon Valley Community Foundation.
He received an MBA from Harvard University and graduated with a BA in Economics from the University
of California, San Diego.
ANN MARIE SASTRY
CO-FOUNDER AND CHIEF EXCECUTIVE OFFICER
SAKTI3
Ann Marie Sastry is co-Founder and CEO of Sakti3, an advanced battery company. Sakti3 has been
recognized for its innovations with several technical and business awards, including recognition as an IHS
CERAweek Energy Innovation Pioneer (2014), MIT’s Technology Review as one the World’s 50 Most
Innovative Companies (2012) and the winner of the World’s Top Ten in the Energy Category (2011).
Sastry brings over 25 years’ leadership and technical experience to her role at Sakti3, building a
management team with >100y of experience in finance, manufacturing and technology. She personally
trained the core technical team. She has co-authored over 70 awarded and filed patents and over 100
scientific publications, and delivered over 100 invited lectures at research, government and private
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 09
institutions globally. Sastry has also served as a board member and advisor to government and public
entities, and as a longstanding advisor to protégés in academics, industry and government.
Prior to leading Sakti3, Sastry was the Arthur F. Thurnau Professor of Mechanical, Biomedical and
Materials Science and Engineering at the University of Michigan. Tenured and promoted early, she
founded and led two research centers in batteries (funding: DOE, GM) and bioscience (funding: Keck
Foundation), and a global graduate program, Energy Systems Engineering. Her laboratory originated the
technical work that underpins Sakti3 technology, and was continuously funded by the DOE for over 17
years. She also led work sponsored by NSF, NIH, Army, ONR, DARPA, Ford, LBNL, and ORNL. She has
received several of the highest technical honors in her field, including the ASME Frank Kreith Energy
Award (2011), ASME Gustus Larson Award (2007) and the NSF's PECASE (1997). She holds Ph.D. and
M.S. degrees from Cornell University (NSF Graduate Fellowship) and a BS from the University of
Delaware (DuPont Scholar), all in Mechanical Engineering.
SUE SIEGEL
CHIEF EXECUTIVE OFFICER
GE VENTURES & HEALTHYMAGINATION
Sue Siegel works on GE’s growth and innovation initiatives as CEO of two company-wide platforms: GE
Ventures, which partners entrepreneurs with GE capabilities and investments, and healthymagination,
which harnesses innovation and partnership to drive better health outcomes. Sue is a 25-year industry
leader with corporate and venture capital experience in growing technology companies in biomedical
research and healthcare. Prior to joining GE, she was a General Partner at Mohr Davidow Ventures, after
a successful career as a C-suite executive. Sue is a Crown Fellow at the Aspen Institute and has been
featured in the bestselling business book Multipliers: How The Best Leaders Make Everyone Smarter and
was recognized as one of “The 100 Most Influential Women in Silicon Valley.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 010
doc_265704577.pdf
Description tell about chairman emeritus retired chairman and chief executive officer rockwell partner.
UC Innovation Council
DONALD R. BEALL
Chairman Emeritus/Retired Chairman & CEO
Rockwell
Partner, Dartbrook Partners, LLC
JAMES BRAILEAN
co-Founder & Managing Partner of
BFT Equity Partners and KARMEL Capital
BROOK BYERS
Senior Partner
Kleiner, Perkins, Caufield & Byers
FRED COHEN
Partner,TPG
co-Founder,TPG Biotechnology
MARK CROWELL
Innovation and Business Development
Consultant
(former) Executive Director, University of
Virginia
JERRY FIDDLER
Founder
Wind River Systems
RODNEY GLOVER
Partner (retired)
Wiley Rein, LLP
JOSH GREEN
General Partner
Mohr Davidow
Chairman
BRUCE HALLETT
Managing Director
Miramar Venture Partners
LESLIE HICKLE
VP Business Development
BioAtla
HADI MAKARCHIAN
Regent of the University of California
Chairman, Makar Properties
Board of Directors and Banning Lewis Ranch
Management Company
ALAN MENDELSON
Partner
Latham & Watkins LLP
TONY OLIVEIRA
Senior Advisor
AGR Partners
Managing Partner, Oliveira Farming
NANCY OLSON
Managing Partner (retried)
Fog City Fund
KISH RAJAN
Director
Governor’s Office of Business and Economic
Development
EDUARDO RALLO
Managing Partner
Pacific Community Management
ANN MARIE SASTRY
co-Founder and CEO
Sakti3
SUE SIEGEL
CEO, GE Ventures &
healthymagination
07.29.2014 Innovation Al liances &
Services
UNIVERSITYOFCALIFORNIA.EDU 01
DONALD R. BEALL
CHAIRMAN EMERITUS
RETIRED CHAIRMAN & CHIEF EXECUTIVE OFFICER
ROCKWELL
PARTNER, DARTBROOK PARTNERS, LLC
Beall retired from Rockwell in 1998 after a 30-year career. He served as Chairman/CEO or
President/COO for 20 years. Rockwell was a global leader in aerospace, electronics and automotive
markets. Through a series of strategic actions, the company became focused on a diversified group of
leadership electronics businesses serving factory automation, communications, avionics and various
communications-semiconductor world markets. Those electronics businesses today are represented by
three public companies through which significant shareowner value has been created.
He is a former director of Amoco, ArvinMeritor, Baker Hughes Corporation, Conexant Systems, CT
Realty, Interfirst Corporation, Mindspeed Technologies, Proctor & Gamble, Rockwell, Rockwell Collins,
Skyworks Solutions and Times Mirror. Currently, he is a partner in Dartbrook Partners, LLC (a family
partnership) and the chairman of the Beall Family Foundation. His wife, J oan, and their two sons, J eff
and Ken, are active in the management of both Dartbrook Partners and the Beall Family Foundation. The
Beall Family Foundation has endowed the Don Beall Dean of Engineering at San J ose State University;
the Donald R. Beall Chair in Strategic Management at the University of Pittsburgh; and $5 million to fund
the Don Beall Center for Innovation and Entrepreneurship at the UCI Paul Merage School of Business,
which has since been transferred to establish the new UCI Institute of Innovation. The Foundation
continues to provide significant annual support to the Beall Center in the Merage School.
Beall is very involved with the University of California Irvine. He serves on several advisory boards and
executive committees in a number of disciplines including: the UCI Paul Merage School of Business
Dean’s Advisory Board, Executive Committee, and the Don Beall Center for Innovation and
Entrepreneurship Advisory Board; UCI Henry Samueli School of Engineering Advisory Board; UCI J oan
and Don Beall Center for Art +Technology Advisory Board; UCI Medical Center CEO Advisory Board;
Advisor to the newly-appointed Executive Director of the UCI Institute for Innovation and member of the
UCI Chief Executive Roundtable. He is an advisor to the San J ose State University School of
Engineering and member of the Engineering Leadership Council. He is a trustee and President’s Circle
member of the Naval Postgraduate School Foundation, and serves as an Overseer of the Hoover
Institution at Stanford. Beall’s membership involvements include: Business Executives for National
Security; The Presidents’ Circle of National Academies of Science, Engineering & Medicine; the Old
Capital Club of Monterey; the Bohemian Club of San Francisco; numerous Young Presidents
Organization alumni groups; and member and past chairman of the Conquistadores del Cielo. He is a
Fellow of the American Institute of Aeronautics and Astronautics. Beall was a member of the board of
governors and past chairman of the Aerospace Industries Association of America (AIA) and was a trustee
of the California Institute of Technology for many years.
Upon his retirement, Beall and his wife, J oan, were honored by Rockwell through the initial funding and
establishment of the J oan and Don Beall Center for Art +Technology, UCI. Continuing significant support
for the Center is provided by the Beall Family Foundation. Other past honors include: 2014 Claire Trevor
Commemorative Star, UCI Claire Trevor School of the Arts, shared with J oan; 2008 SJ SU Tower Award (San
J ose State University's highest honor); 2001 UCI Medal; 1998 Horatio Alger Award; 1996 Human Relations
Award from the Orange County Chapter of the American J ewish Committee, shared with J oan; and 1996
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 01
Front & Center Award as Orange County Person of the Year, presented by California State University
Fullerton.
Beall received an engineering degree from San J ose State University and an MBA from the University of
Pittsburgh. Both institutions have honored Beall with distinguished alumnus awards. Beall also received
the 1991 Exemplary Leadership in Management Award from the J ohn E. Anderson School of
Management, UCLA. He is involved in numerous professional, educational, public service and
philanthropic endeavors and is an investor, director, and/or advisor with several venture capital groups,
individual companies and investment partnerships.
Beall has been married for more than 50 years to J oan. They have two married sons, two
granddaughters, three grandsons and one great-grandson. They reside in Corona del Mar and Pebble
Beach, California.
JAMES C. BRAILEAN
CO-FOUNDER AND MANAGING PARTNER
BFT EQUITY PARTNERS AND KARMEL CAPITAL
J ames Brailean, PhD, is the co-founder and managing partner of BFT Equity Partners and KARMEL
Capital. Dr. Brailean started BFT Equity Partners in J anuary of 2013. The fund focuses on investments in
early stage companies with disruptive technology or manufacturing processes. The fund has made five
investments ranging from Intelligent Blends, manufacturer of single serve drinks, to BURL Concepts, a
company developing a portable medical device to enable the detection of stroke in pre-hospital settings.
KARMEL Capital was founded by Dr. Brailean and his partner Scott Neuberger. KARMEL Capital is a
Private Equity fund with a focus on unlocking value by bringing operational excellence and strategic
direction to technology companies. KARMEL’s principals partner with current investors/owners to create a
turnaround strategy and a win/win deal structure for all stakeholders. In J une of 2013, KARMEL Capital
acquired 85% of the Qualcomm subsidiary, Snaptracs. In March of 2014 Karmel Capital successfully
partnered with Parallax Partners and Stepstone Capital to acquire the DivX business unit from Rovi
Corporation (NASDAQ ROVI). Dr. Brailean is currently serving as a director on the board of directors of
both Snaptracs and DivX.
Prior to starting BFT Equity Partners and KARMEL Capital, Dr. Brailean founded PacketVideo in 1998
and became its CEO in 2000. Under Dr. Brailean's leadership, PacketVideo launched the world's first
commercial end-to-end wireless mobile media delivery platform in 2000, and helped create a new
industry for wireless multimedia communications. PacketVideo was acquired by NTT DOCOMO, a large
J apanese telecommunications company, in October 2010. In J anuary of 2013 after 14.5 years of leading
PacketVideo and shipping more than 700 million pieces of software worldwide, Dr. Brailean stepped
down as CEO.
Dr. Brailean has previously served on several public and private company boards including DivX
(NASDAQ DIVX), Sonic Solutions (SNIC), NextWave (NASDAQ WAVE), Wireless On-ramp, Perseus
Wireless, and Nik Software. Currently, Dr. Brailean serves on the boards of Micropower Technologies,
Inteligent Blends, Burl Concepts, Snaptracs and DivX. Dr. Brailean also served on both AT&T’s and
Verizon Wireless’ Application Developer Advisory Boards from 2007 to 2010. From 2000 to 2004, Dr.
Brailean served on the advisory board of DOCOMO Labs USA..
Dr. Brailean received his doctorate of philosophy in electrical engineering from Northwestern University.
He holds a MSEE from USC and a BSEE from the University of Michigan - Dearborn. Dr. Brailean has 17
patents in the area of video compression and transmission. He is a recipient of the Lifetime Achievement
Award from the Mobile Entertainment Forum for his contributions to the acceleration of the development
and adoption of mobile multimedia services worldwide.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 02
BROOK BYERS
SENIOR PARTNER
KLEINER, PERKINS, CAUFIELD & BYERS
A venture capital investor since 1972, Brook has been closely involved with more than 60 new
technology-based ventures, many of which have become public companies. He formed the first life
sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier
venture capital firm in the medical, healthcare and biotechnology sectors. KPCB has invested in and
helped build more than 110 life sciences companies that have developed hundreds of products to treat
underserved medical needs for many millions of patients. Brook was the founding president and then
chairman of four biotechnology companies that were incubated in KPCB's offices and went on to become
public companies with an aggregate market value of more than US$8 billion. He serves on the board of
directors of CardioDX, Crescendo, Elcelyx, Foundation Medicine, Oculeve, Pacific Biosciences, Inc.,
Veracyte, XDx, Inc. and Zephyr Health. Formerly, Brook served as a director of Idec Pharmaceuticals
(chairman), Athena Neurosciences (chairman), Signal Pharmaceuticals, Onyx Pharmaceuticals, Hybritech
(chairman), Genprobe and others. These companies pioneered the medical use of molecular biology,
monoclonal antibodies, personalized medicine, molecular diagnostics, genomics and sequencing. He also
previously served as the president and a director of the Western Association of Venture Capitalists. Brook
is on the Board of Trustees of Stanford University, a board member of the University of California, San
Francisco, Medical Foundation and the New Schools Foundation. In 2007, UCSF awarded Brook the
UCSF Medal, its honorary degree equivalent. In 2008, Brook was elected a fellow of the American
Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National
Venture Capital Association. In 2010, he received an honorary Ph.D. from Georgia Institute of
Technology. Brook is a former director of the Entrepreneurs Foundation, the Asian Art Museum in San
Francisco and the Georgia Tech Advisory Board. He was also a founder of TechNet. Raised in Atlanta,
Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and
received an M.B.A. from Stanford University.
FRED E. COHEN
PARTNER, TPG
CO-FOUNDER, TPG BIOTECHNOLOGY
Fred Cohen is a Partner at TPG and co-founder of TPG Biotechnology, a life science focused investment
effort. He is also an Adjunct Professor of Cellular and Molecular Pharmacology at the University of
California, San Francisco.
For the last 13 years, Dr. Cohen has been at TPG where he has been responsible for co-leading the
Biotechnology investment effort. The Biotechnology team has invested in over 50 companies covering
areas of Drug Discovery and Development, Personalized Medicine, Allied Pharmaceutical Services,
Industrial Biotechnology and Medical Technology. The group was formed in 2002 and has recently
initiated its fourth fund. Currently, TPG Biotechnology manages over $1 Billion in assets and is an
integral part of the firm’s larger healthcare efforts.
For the last 30 years, Dr. Cohen has been at UCSF where he has held various clinical responsibilities as
an Internist for hospitalized patients, a consulting Endocrinologist, and as the Chief of the Division of
Endocrinology and Metabolism. His research interests include structure based drug design, prion
diseases, computational biology and heteropolymer chemistry. Dr. Cohen has published over 200 peer
reviewed articles, participated as a co-inventor on over 10 patents and has served as an editor or editorial
board member of several international scientific journals.
Dr. Cohen received his BS degree in Molecular Biophysics and Biochemistry from Yale University, his
D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his MD from Stanford and his
postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 03
He is a Fellow of the American College of Physicians and the American College of Medical Informatics
and a member of the American Society for Clinical Investigation and Association of American Physicians.
Dr. Cohen has received several awards for his work including a Searle Scholarship, Young investigator
awards from the Endocrine Society and the Western Society for Clinical Investigation, and the LVMH
Science pour l’art prize (shared with Stanley Prusiner). Dr. Cohen was elected to the Institute of Medicine
of the National Academy of Sciences in 2004 and the American Academy of Arts and Sciences in 2008.
Dr. Cohen currently serves on the Board of Directors of several biotechnology and pharmaceutical
organizations including Biocryst(BCRX), CareDx(CDNA), Five Prime Therapeutics(FPRX), Genomic
Health(GHDX), Quintiles Transnational(Q), Rapid Micro Biosystems, Roka(ROKA), Tandem
Diabetes(TNDM), and Veracyte(VCYT). He also serves on the board of Autistica, a UK based autism
research charity.
Fred lives in San Francisco with his wife, Carolyn Klebanoff M.D., and his three children, Alison, Michael
and J ane. Drs. Klebanoff and Cohen were founders of Sweetwater Spectrum, a non-profit organization
that creates and runs planned communities for adults with autism. Dr. Klebanoff currently serves as the
Board Chair and Dr. Cohen is a member of the advisory board.
MARK CROWELL
INNOVATION AND BUSINESS DEVELOPMENT CONSULTANT
(FORMER) EXECUTIVE DIRECTOR, UNIVERSITY OF VIRGINIA
Mark Crowell is an internationally-known practitioner and consultant in areas related to university
innovation and business development, proof-of-concept and translational research initiatives, university-
industry (and foundation) research partnerships, and innovation and entrepreneurial ecosystem
development strategies. Mark currently consults for and advises such organizations as the World Bank,
BIO, PhRMA, the Arkansas Research Alliance, Eva Klein & Associates, Maximus, Research Triangle
Institute, and a number of university clients.
From 2010-2014, Mark was the founding Executive Director of UVa Innovation at the University of
Virginia (and Associate Vice President for Research). In one of the nation’s first pan-university “chief
innovation officer” roles, Mark led the re-engineering and integration of the university’s technology
transfer, business development, industry and foundation research, and innovation policy and advisory
services; in addition, he worked to establish collaborative mechanisms between UVa Innovation and
entrepreneurship education, innovation challenge, Darden iLab, Open Grounds, and related initiatives
across the university. Key accomplishments within UVa during Mark’s tenure included numerous new
company launches, accelerated time frames for “lab to market” for promising UVa discoveries, enhanced
numbers of licenses and partnerships with industry and foundations, and a national “best-in-class”
process for managing translational research and proof-of –commercial-readiness projects. In May 2014,
the US Chamber of Commerce recognized UVa Innovation with its “Champion of Intellectual Property”
Award for its work in advancing innovation and intellectual property.
Mark advises key leaders and policy development groups, including the NIH, US Congress, AAMC
Council of Deans, and many others. He testified twice in Congress about the critical need for more
resources to address the “translational gap” between basic discovery and market readiness, leading to
the introduction of a key piece of legislation, the “Transfer Act of 2013”, in which his testimony was cited
as a catalyst for newly proposed initiatives. As a result of his effectiveness in advocating for support for
best practices in university innovation management, Mark was invited by the White House to the
presidential signing ceremony for the America Invents Act.
While leading UVa Innovation, Mark was – and remains – extremely active and engaged in national and
international advisory and advocacy work related to university innovation and business development. He
chairs BIO’s Technology Transfer Committee and has chaired the Translational Research Forum at the
last four BIO International Conventions. His impact and visibility leads to frequent invitations to speak
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 04
and share best practices in settings around the US, including a fall 2013 invitation from the Office of US
Senator Max Baucus to speak at the Montana J obs Summit 2013 (featuring speakers like Elon Musk,
Sheryl Sandberg, and other prominent CEOs of Fortune 500 and high growth, high success startups).
Mark’s most recent international consulting work includes innovation capacity building initiatives in
Eastern Europe on behalf of the World Bank, innovation policy and best practices advisory projects in
South America on behalf of BIO, and keynote addresses at international conferences and symposia in
such places at Singapore, China, Thailand, J apan, and Brazil.
Before going to UVa in 2010, Mark served as Vice President for Business Development at the Scripps
Research Institute in La J olla, CA, and J upiter, FL, following a long career in Research Triangle Park,
North Carolina, where he led the innovation, technology transfer, and industry research enterprises for
Duke (1987-1992), North Carolina State University (1992-2000), and the University of North Carolina at
Chapel Hill (2000-2008). During the past 25 years, the technology transfer programs Mark has directed
have helped to launch more than 135 start-up companies, as well as numerous products and services.
He also played a major role in the development of research campuses in the Research Triangle region
and co-founded a university-related venture capital fund.
Crowell was the 2005 President of the Association of University Technology Managers (AUTM). In 2013,
he was awarded AUTM’s highest award, the “Bayh-Dole Award”, given “in recognition of the recipient’s
untiring efforts to foster and promote intellectual property activities on behalf of the university and
nonprofit community.”
JERRY FIDDLER
FOUNDER
WIND RIVER SYSTEMS
J erry Fiddler is the founder of Wind River Systems (NASDAQ:WIND), a company which he started in
1981 in his Berkeley garage. Since then, Wind River has grown to become the leading provider of device
software worldwide with over 1,100 employees in 16 countries. Through the company's dramatic growth,
Fiddler's role evolved from that of the sole programmer to CEO and Chairman of the Board until his
departure in 2004. While doing so, he gained a reputation as an expert in the design and implementation
of real-time systems." Since beginning his career at Lawrence Berkeley Lab, Fiddler has published and
presented many technical papers and articles and has been the keynote speaker for numerous
conferences worldwide. Mr. Fiddler sits on several corporate boards, including Wind River, Tensilica,
Crossbow and Nanochip, as well as a number of advisory boards.
RODNEY H. GLOVER
PARTNER (RETIRED)
WILEY REIN, LLP
After thirty years of the practice of law in Washington, DC, Mr. Glover retired in 2009. During his career,
his practice focused primarily on representing venture capital firms and technology-based companies
providing services including corporate litigation, analyzing and negotiating corporate acquisitions and
serving as outside general counsel to some of his long-standing clients. Mr. Glover also represented
several science-based not-for-profits on a variety of issues including corporate governance, compliance,
government contracts, employment matters and day-to-day legal operations.
Mr. Glover served as counsel for and later as a board member of the Bermuda Institute of Ocean
Sciences (“BIOS”) from 2006-10 where he provided advice on matters such as ship acquisitions, appeals
from NSF grant denials, and a wide variety of corporate matters. After moving to the San Diego area Mr.
Glover joined the Advisory Council of Scripps Institution of Oceanography in 2012. In 2013 he was
selected to join the UCSD Innovation Advisory Board where he has worked on a number of projects to
advance innovation there.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 05
Mr. Glover’s interest in ocean science is a continuation of his life-long passion for the oceans that began
as a child during family vacations on Cape Cod. This interest was further kindled during his sophomore
year at the University of Maryland when he was selected by the Department of Defense to be one of eight
undergraduates to spend 4 months on an oceanographic research vessel in the Pacific and Indian
Oceans conducting surveys and experiments relating to tectonic plate shifting and sea-floor “hot spots.”
JOSH GREEN
GENERAL PARTNER
MOHR DAVIDOW VENTURES
J osh Green has been a venture capitalist since 2006 and his investments include a wide range of
startups and today is focused on places where information technology meets the analog world.
In a 25-year career in law prior to venture capital, J osh built two law firms to 150 lawyers each and acted
as an advisor to some of Silicon Valley’s legendary startups in the computer, Internet,
telecommunications, biotech and medical device industries. J osh gained a breadth of knowledge that
makes him uniquely qualified for an investment area that spans multiple industries. He served as
Chairman of the National Venture Capital Association in a term ended May 2014.
Facts & Stats
Graduated magna cum laude from UCLA in 1977 and the UCLA School of Law in 1980 where he was on
the Law Review
Founder of the UCLA Venture Capital Fund,
Undergraduate commencement speaker at UCLA
High school basketball coach for eight years
Formerly included on Forbes Midas List of dealmakers
J osh helped more than 150 companies complete successful IPOs, over 100 companies complete M&A
transactions and 1000 venture capital financings
Favorite Quote: “Be more concerned with your character than your reputation, because your character is
what you really are, while your reputation is merely what others think you are” – Legendary UCLA Head
Basketball Coach J ohn Wooden.
BRUCE HALLETT
MANAGING DIRECTOR
MIRAMAR VENTURE PARTNERS
Bruce Hallett is a co-founder of Miramar Ventures and brings his enthusiasm for innovation, product
strategy and team building to Miramar’s portfolio of tech start-up companies. With over two decades of
collaborations with technology entrepreneurs, Bruce leads Miramar investments in mobile Internet
solutions and software. Currently, he serves on the board of directors of Brand Affinity Technologies and
WellTok. He also served on the boards of Aktino (acquired by Positron), Berkana Wireless (acquired by
Qualcomm), OptionEase (acquired by Solium) and RealPractice (acquired by ReachLocal).
Prior to founding Miramar, Bruce was Managing Partner of the Brobeck, Phleger & Harrison Orange
County office, where he orchestrated initial public offerings, venture financings and liquidity events for
many high profile technology companies in Southern California, including Broadcom, Buy.com, Exult and
Applied Semantics (acquired by Google in 2003). Bruce was one of seven partners on Brobeck’s firm-
wide executive committee until he started Miramar in 2001.
Bruce received his BA magna cum laude from UC Irvine and his J D from UCLA. He is currently President
of the UC Irvine Alumni Association. From 2007-2010, he was Chair of the Chief Executive Roundtable
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 06
at UC Irvine, a group of business leaders committed to building mutually beneficial, strategic partnerships
between the university and the community. Bruce also serves on the Board of Directors of OCTANe.
From 2010-2012, Bruce served as UC Alumni Regent on the Board of Regents of the University of
California.
LESLIE HICKLE
VICE PRESIDENT BUSINESS DEVELOPMENT
BIOATLA
Dr. Leslie Hickle is Vice President Business Development for BioAtla, a San Diego biopharmaceutical
company developing novel drugs and protein engineering platforms based on bioactive proteins such as
antibodies and enzymes. She has extensive research and management leadership experience in animal
health, agribusiness, and industrial biotechnology and transactional experience across multiple industries
leading to several legacy products with multi-million dollar sales. Prior to joining BioAtla, she managed the
San Diego headquarters and led corporate development for Synthetic Genomics, a company founded by
Dr. Craig Venter to progress the development of biobased fuels and synthetic biology. Previous to SGI,
while at Diversa, AgriLynx, Mycogen and Stauffer Chemical (now Syngenta) she played critical rolls in
identifying and fostering strategic alliances with key partners in animal health, plant agriculture and
industrial businesses. She has led and mentored teams that have developed novel chemical and
biopesticides, plant traits, vaccines, therapeutics, and technology platforms; she is co- inventor on issued
and pending patents, is editor of a book on analytical chemistry, and co-author of publications in animal
health and agriculture. She has founded successful biotech companies and served as a business and
technical consultant to Bayer, California EPA, Schering Plough, Pioneer Hi-Bred, DuPont, Dow Chemical,
Cal Poultry Federation and several biotech startups. Dr. Hickle received both her BS (1974,
Biology/Chemistry) and PhD (1981, Entomology/Toxicology) from the University of California Riverside.
Leslie is a Certified Board of Director (UCLA Anderson School of Business) and continues to advise and
work with new biotech startups; she also serves on UC Riverside Board of Advisors for the College of
Natural and Agricultural Sciences.
HADI MAKARECHIAN
REGENT OF THE UNIVERSITY OF CALIFORNIA
CHAIRMAN, MAKAR PROPERTIES
BOARD OF DIRECTORS AND BANNING LEWIS RANCH MANAGEMENT COMPANY
Hadi Makarechian serves as Chairman of Makar Properties Board of Directors and Banning Lewis Ranch
Management Company. He received his B.S. in Civil Engineering and his B.A. in Economics from the
State University of New York. Prior to his retirement in J une 2008, Mr. Makarechian served as chief
executive officer and chairman of the board of directors of Capital Holdings, Inc., a company he founded
in 1991. He also founded and served as president of Shamron Corporation from 1979 to 1991.
ALAN C. MENDELSON
PARTNER
LATHAM & WATKINS LLP
Mr. Mendelson is a corporate attorney, primarily representing biotechnology and medical device emerging
and growth companies and has been a partner at Latham & Watkins LLP since 2000. He currently
serves as co-chair of Latham’s Life Science Industry Group and served as co-chair of its Emerging
Companies Practice Group from 2001-13. Prior to joining Latham, he was with Cooley LLP from 1973-
2000.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 07
Mr. Mendelson served as president and a board member of the National Kidney Foundation of Northern
California, Inc. for fifteen years, as a member of the Board of Overseers Visiting Committee of Harvard
Law School for six years, as a member of the Board of Trustees of The Scripps Research Institute from
2012-14. Mr. Mendelson served as president of the Cal Alumni Association from 2009-11 and as an
alumni member of the UC Board of Regents from 2011-13. He currently serves as a member of the Major
Gifts Council for the Lucile Packard Foundation for Children's Health and as a member of the Board of the
American Friends of Rambam Medical Center, Haifa, Israel.
Mr. Mendelson has been recognized as one of America's 100 most influential lawyers by the National
Law J ournal in the 1994, 1997, 2000 and 2006 editions of the National Law J ournal. In March 2010, Mr.
Mendelson was honored at the annual Salute to Excellence dinner sponsored by the American Liver
Foundation for those who have made an outstanding contribution to biotechnology and medical
innovation. In 2012, the Cal Alumni Association recognized him for his “Excellence in Service” to UC
Berkeley. In 2013, he was named to Euromoney’s Life Sciences Hall of Fame, and in December 2014,
Mr. Mendelson will receive the Life Sciences Leadership Award from BayBio at its 11th annual Pantheon
Awards ceremony.
TONY OLIVEIRA
SENIOR ADVISOR
AGR PARTNERS; MANAGING PARTNER, OLIVEIRA FARMING
Currently serving as an advisor to AGR, Tony Oliveira brings more than 40 years of experience as a
multinational agribusiness executive, farmer, economics professor and public servant. He is the
managing partner of Oliveira Farming, a diversified farming operation in California's Central Valley.
Oliveira provides consulting services through Oliveira Advisory Services and Funston Advisory Work
Services, both of which focus on pension issues with an emphasis on asset liability and sustainability, and
risk management. He is a practicing economist, advising companies on economic trends with a focus on
agricultural investments and commodity trends. While working as CEO at Dalgety PLC in London for six
years, he was part of a small team that developed revolutionary patents for the fresh produce sector.
Oliveira has also been active in the public sector: he served on the California Public Employees
Retirement System (CalPERS) board, the Kings County Board of Supervisors, and the California State
Association of Counties (CSAC) board. He has also been teaching economics and business at West Hills
College in Lemoore since 2000. Tony received his M.B.A. from Pepperdine University and is a Ph.D
candidate in Public Policy at Walden University, currently completing his dissertation in the sustainability
of public and private pension funds through best practice benchmarking of the asset/liability study (ALS)
process. He has completed Fiduciary and Pension Management programs at Stanford Law School. He is
also a songwriter, composer and performer. He and his wife live in Lemoore.
NANCY OLSON
MANAGING PARTNER (RETIRED)
FOG CITY FUND
Ms. Olson was a venture capitalist for 25 years. She is the retired founder and managing partner of Fog
City Fund, a venture fund that invested in life science and medical companies. She was previously a
general partner at St. Paul Venture Capital and Sequoia Capital. She has served as a trustee of
Hampshire College, a director of the San Francisco Opera Association, and a board member of Girl
Scouts of San Francisco Bay Area. Her UCB campus affiliations include UC Berkeley Foundation trustee
(2001-2013), Graduate Fellowship Advisory Committee, College of Letters & Science Executive Board
(1999-2007) and board president (2004-2007), Health Science Initiative Volunteer Committee, supporter
of the Biology Fellows Program, On the Same Page, and founder/sponsor of IDEAL Scholarships and
SMART program. She is a Builder of Berkeley, a Berkeley Fellow, and recipient of the Trustees’ Citation.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 08
KISH RAJAN
DIRECTOR
GOVERNOR’ S OFFICE OF BUSINESS AND ECONOMIC DEVELOPMENT
Kish Rajan serves as Director of the Governor's Office of Business and Economic Development. He
brings to the job a 20-year track record of success in both government and the private sector. After
graduating from UC Berkeley, Kish Rajan began his public sector career on Capitol Hill as an aide first to
United States Senator Barbara Boxer and then later to Phil Angelides who went on to become California
State Treasurer.
Kish left to build a 14 year career in the private sector as a business development executive in the mobile
technology arena, managing vital business partnerships that created hundreds of jobs and millions of
dollars of shareholder value. While building this successful business career, Kish earned a J D, started a
family, and settled back in his hometown of Walnut Creek, CA. In 2008, Kish re-entered public service
when was elected to the Walnut Creek City Council. Drawing on his political and business experience
Kish became a regional leader who advocated for transportation improvement, education and economic
development. In 2012, Governor Brown appointed Kish Rajan as the GO-Biz director to lead the
executive team. His directive from Governor Brown is to enhance California’s job creation effort by
streamlining business regulations, promoting statewide economic development and fostering greater
international trade opportunities.
EDUARDO RALLO
MANAGING PARTNER
PACIFIC COMMUNITY MANAGEMENT
Eduardo Rallo is Managing Partner of Pacific Community Management, a leading impact investing firm,
and sits on the boards of ICU Eyewear, Freshology, and Pacific Pharmacy Group.
Additionally, Eduardo is Chairman and Co-Founder of Resmex Group, Inc., which manages six restaurant
concepts in the Bay Area and has over 400 employees. He is also Co-Founder of Milagros de Mexico a
pharmacy chain focused on the Hispanic market. Prior to joining PCV, Mr. Rallo co-founded World
Wrapps Restaurants and oversaw its growth to a 26-store chain. Mr. Rallo also co-founded and served
as Managing Director of BrainStorm Ventures, an early stage investment fund, which has invested in 24
companies, including Opentable.com, Zappos.com and Me.com.
Eduardo sits on the non-profit boards of Universal Giving and Silicon Valley Community Foundation.
He received an MBA from Harvard University and graduated with a BA in Economics from the University
of California, San Diego.
ANN MARIE SASTRY
CO-FOUNDER AND CHIEF EXCECUTIVE OFFICER
SAKTI3
Ann Marie Sastry is co-Founder and CEO of Sakti3, an advanced battery company. Sakti3 has been
recognized for its innovations with several technical and business awards, including recognition as an IHS
CERAweek Energy Innovation Pioneer (2014), MIT’s Technology Review as one the World’s 50 Most
Innovative Companies (2012) and the winner of the World’s Top Ten in the Energy Category (2011).
Sastry brings over 25 years’ leadership and technical experience to her role at Sakti3, building a
management team with >100y of experience in finance, manufacturing and technology. She personally
trained the core technical team. She has co-authored over 70 awarded and filed patents and over 100
scientific publications, and delivered over 100 invited lectures at research, government and private
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 09
institutions globally. Sastry has also served as a board member and advisor to government and public
entities, and as a longstanding advisor to protégés in academics, industry and government.
Prior to leading Sakti3, Sastry was the Arthur F. Thurnau Professor of Mechanical, Biomedical and
Materials Science and Engineering at the University of Michigan. Tenured and promoted early, she
founded and led two research centers in batteries (funding: DOE, GM) and bioscience (funding: Keck
Foundation), and a global graduate program, Energy Systems Engineering. Her laboratory originated the
technical work that underpins Sakti3 technology, and was continuously funded by the DOE for over 17
years. She also led work sponsored by NSF, NIH, Army, ONR, DARPA, Ford, LBNL, and ORNL. She has
received several of the highest technical honors in her field, including the ASME Frank Kreith Energy
Award (2011), ASME Gustus Larson Award (2007) and the NSF's PECASE (1997). She holds Ph.D. and
M.S. degrees from Cornell University (NSF Graduate Fellowship) and a BS from the University of
Delaware (DuPont Scholar), all in Mechanical Engineering.
SUE SIEGEL
CHIEF EXECUTIVE OFFICER
GE VENTURES & HEALTHYMAGINATION
Sue Siegel works on GE’s growth and innovation initiatives as CEO of two company-wide platforms: GE
Ventures, which partners entrepreneurs with GE capabilities and investments, and healthymagination,
which harnesses innovation and partnership to drive better health outcomes. Sue is a 25-year industry
leader with corporate and venture capital experience in growing technology companies in biomedical
research and healthcare. Prior to joining GE, she was a General Partner at Mohr Davidow Ventures, after
a successful career as a C-suite executive. Sue is a Crown Fellow at the Aspen Institute and has been
featured in the bestselling business book Multipliers: How The Best Leaders Make Everyone Smarter and
was recognized as one of “The 100 Most Influential Women in Silicon Valley.
08.05.2014 Innovation Al liances & Services UNIVERSITYOFCALIFORNIA.EDU 010
doc_265704577.pdf